Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meri

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical & Laboratory Immunology|April 1, 1990
High frequencies of B8, DR3 and C4A null alleles and immunological disorders in a family of four generationsM L Lokki, S Meri, J Partanen, et al.
FEBS Letters|November 27, 1995
Extracellular domain of type I receptor for transforming growth factor-beta: molecular modelling using protectin (CD59) as a templateT S Jokiranta, J Tissari, O Teleman, et al.
Annals of the Rheumatic Diseases|March 1, 1988
Complement activation and HLA-B27S Meri, J Partanen, M Leirisalo-Repo, et al.
Scandinavian Journal of Immunology|April 28, 2006
Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapyL Bjørge, H Stoiber, M P Dierich, et al.
Perfusion|January 1, 1990
Comparison of hollow fibre membrane oxygenators during cardiopulmonary bypass in children: Dideco Masterflo versus Terumo Capiox IIM Leijala, K Peltola, M Aronen, et al.
Clinical and Experimental Immunology|June 1, 1985
Complement levels and C3 breakdown products in open-heart surgery: association of C3 conversion with the postpericardiotomy syndromeS Meri, K Verkkala, A Miettinen, et al.
The American Journal of Pathology|April 1, 1996
Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomasA Mäenpää, S Junnikkala, J Hakulinen, et al.
Journal of Veterinary Internal Medicine|October 1, 2017
Antihistone Autoantibodies in Dobermans With HepatitisH Dyggve, S Meri, T Spillmann, et al.
International Journal of Cancer|January 6, 1997
Complement-regulatory proteins in ovarian malignanciesL Bjørge, J Hakulinen, T Wahlström, et al.
Immunology|May 1, 1994
High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasmaA Väkevä, M Jauhiainen, C Ehnholm, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical & Laboratory Immunology|April 1, 1990
High frequencies of B8, DR3 and C4A null alleles and immunological disorders in a family of four generationsM L Lokki, S Meri, J Partanen, et al.
FEBS Letters|November 27, 1995
Extracellular domain of type I receptor for transforming growth factor-beta: molecular modelling using protectin (CD59) as a templateT S Jokiranta, J Tissari, O Teleman, et al.
Annals of the Rheumatic Diseases|March 1, 1988
Complement activation and HLA-B27S Meri, J Partanen, M Leirisalo-Repo, et al.
Scandinavian Journal of Immunology|April 28, 2006
Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapyL Bjørge, H Stoiber, M P Dierich, et al.
Perfusion|January 1, 1990
Comparison of hollow fibre membrane oxygenators during cardiopulmonary bypass in children: Dideco Masterflo versus Terumo Capiox IIM Leijala, K Peltola, M Aronen, et al.
Clinical and Experimental Immunology|June 1, 1985
Complement levels and C3 breakdown products in open-heart surgery: association of C3 conversion with the postpericardiotomy syndromeS Meri, K Verkkala, A Miettinen, et al.
The American Journal of Pathology|April 1, 1996
Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomasA Mäenpää, S Junnikkala, J Hakulinen, et al.
Journal of Veterinary Internal Medicine|October 1, 2017
Antihistone Autoantibodies in Dobermans With HepatitisH Dyggve, S Meri, T Spillmann, et al.
International Journal of Cancer|January 6, 1997
Complement-regulatory proteins in ovarian malignanciesL Bjørge, J Hakulinen, T Wahlström, et al.
Immunology|May 1, 1994
High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasmaA Väkevä, M Jauhiainen, C Ehnholm, et al.
Pageof 16